AstraZeneca (AZN) halts Truqap trial for prostate cancer after an independent review finds it unlikely to meet survival or progression goals
https://seekingalpha.com/news/4436917-astrazeneca-discontinues-truqap-trial-in-castration-resistant-prostate-cancer
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.